Page last updated: 2024-08-24

gemcitabine and Pancreatic Diseases

gemcitabine has been researched along with Pancreatic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Biankin, AV; Blackwell, A; Chambers, CR; Charlton, B; Chitty, JL; Clark, SJ; Cox, TR; Croucher, DR; Da Silva, AM; Filipe, EC; Findlay, AD; Gill, AJ; Grant, RD; Grimmond, SM; Hastings, JF; Herrmann, D; Jarolimek, W; Johns, AL; Latham, SL; Lucas, MC; Major, G; Melenec, P; Mok, ETY; Murphy, KJ; Nadalini, A; Nagrial, A; Nobis, M; Pajic, M; Papanicolaou, M; Parker, AL; Pereira, BA; Perryman, L; Phillips, PA; Pidsley, R; Ratnaseelan, S; Reed, DA; Ritchie, SC; Russo, A; Setargew, YFI; Sharbeen, G; Skhinas, JN; Stoehr, J; Tayao, M; Timpson, P; Tran, E; Trpceski, M; Velayuthar, S; Vennin, C; Wyllie, K; Yam, M; Youkhana, J; Zaratzian, A	1

Studies

Biankin, AV; Blackwell, A; Chambers, CR; Charlton, B; Chitty, JL; Clark, SJ; Cox, TR; Croucher, DR; Da Silva, AM; Filipe, EC; Findlay, AD; Gill, AJ; Grant, RD; Grimmond, SM; Hastings, JF; Herrmann, D; Jarolimek, W; Johns, AL; Latham, SL; Lucas, MC; Major, G; Melenec, P; Mok, ETY; Murphy, KJ; Nadalini, A; Nagrial, A; Nobis, M; Pajic, M; Papanicolaou, M; Parker, AL; Pereira, BA; Perryman, L; Phillips, PA; Pidsley, R; Ratnaseelan, S; Reed, DA; Ritchie, SC; Russo, A; Setargew, YFI; Sharbeen, G; Skhinas, JN; Stoehr, J; Tayao, M; Timpson, P; Tran, E; Trpceski, M; Velayuthar, S; Vennin, C; Wyllie, K; Yam, M; Youkhana, J; Zaratzian, A

Other Studies

1 other study(ies) available for gemcitabine and Pancreatic Diseases

Article	Year
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Nature cancer, 2023, Volume: 4, Issue:9 Topics: Gemcitabine; Humans; Pancreatic Diseases; Pancreatic Neoplasms; Protein-Lysine 6-Oxidase	2023